Semaglutide, on the other hand, has been extensively studied and is approved by the FDA for weight loss
Finally, there are mechanisms of action of these GLP-1s that we don't completely understand.
This dual approach may result in a more pronounced reduction in appetite, aiding individuals in adhering to caloric restrictions and making healthier food choices
Rather than relying on guesswork, patients can receive guidance based on their individual situation
However, this same effect creates the physiological basis for common adverse effects including nausea, vomiting, early satiety, bloating, and belching
Alaniz JR, Avila J, Cantu KR, Cruz JF, De La Cruz H, Jaramillo A, Sanchez FL, Pena G, Salinas A, Viera SF, Cantu K, Garcia JR